On 15 March 2017, the Board of Directors of Targovax ASA approved the financial statements for 2016 for issuance, subject to approval by the Annual General meeting on April 5, 2017.
Please find attached the Annual Report with financial statements for 2016.
For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Source: Targovax ASA